维生素D、ω-3补充或家庭运动方案对肌肉质量与肌少症的影响:DO-HEALTH试验
本研究为DO-HEALTH试验的次要终点分析,纳入2157名70岁以上健康社区老年人,随机接受每日2000 IU维生素D、每日1 g海洋ω-3和/或每周三次家庭运动,2×2×2析因设计。结果显示,与对照相比,上述干预单独或联合均未改善3年四肢骨骼肌质量指数(ALMI)变化,也未降低肌少症发病风险。
要点
- 每日2000 IU维生素D、1 g ω-3或家庭运动单独或联合均未改善3年ALMI变化。
- ω-3仅在1年时对ALMI有轻微保护作用,3年时无显著获益。
- 上述干预均未降低3年肌少症发病风险。
核心结论
- 在健康、体力活动的老年人中,每日2000 IU维生素D、每日1 g ω-3或简单家庭运动方案与对照相比,3年内未改善ALMI或肌少症发病率。
研究设计与样本
- DO-HEALTH为3年随机双盲安慰剂对照试验,2×2×2析因设计,纳入2157名70岁以上健康社区老年人,2012至2018年进行。
- ALMI变化分析纳入1495名接受DXA检查者,肌少症发病分析纳入1940名基线非肌少症者。
主要发现
- 3年时ALMI平均变化女性为-0.09 kg/m²(-1.35%),男性为-0.17 kg/m²(-2.0%)。
- ω-3仅在1年时对ALMI有轻微保护作用(-0.021 vs 无ω-3 -0.066 kg/m²,p=0.001)。
- 1940名基线非肌少症者中88名(4.5%)在3年内发生肌少症。
- 各干预单独或联合均未降低肌少症发病 odds(与安慰剂相比)。
关键数值与推荐
- 维生素D剂量为每日2000 IU,ω-3剂量为每日1 g海洋ω-3,运动为每周三次家庭运动方案。
- 肌少症诊断基于Sarcopenia Definitions and Outcomes Consortium标准。
临床怎么用
- 对于健康、体力活动的70岁以上老年人,不应仅依赖维生素D、ω-3或家庭运动来改善肌肉质量或预防肌少症。
- 临床决策应结合老年综合评估,考虑其他干预措施。
局限性
- 本研究为次要终点分析,研究对象为健康、体力活动较好的社区老年人,结果外推需谨慎。
- ALMI分析仅纳入接受DXA检查的1495名参与者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We aimed to investigate the effect of daily supplemental vitamin D, omega-3s, and a thrice-weekly home exercise program, alone or in combination, on change of appendicular lean muscle mass index (ALMI) and incident sarcopenia in older adults. METHODS: This is a secondary endpoint analysis of a 3-year randomized, double-blind, placebo-controlled trial with a 2 × 2 × 2 factorial design among 2157 community-dwelling, healthy adults aged 70 + years, from 2012 to 2018 (DO-HEALTH). Participants were randomized to 2000 IU/d vitamin D and/or 1 g/d marine omega-3s and/or exercise. Change in ALMI over 3 years was calculated in all participants who underwent dual energy X-ray absorptiometry (DXA) (n = 1495) using mixed effect models. Incident sarcopenia was analyzed based on the Sarcopenia Definitions and Outcomes Consortium in all non-sarcopenic participants (n = 1940). RESULTS: Among 1495 participants (mean age 74.9 (sd 4.4); 63.3% were women; 80.5% were at least moderately physically active at baseline) mean gait speed at baseline was 1.2 m/s (sd 0.3), mean ALMI at baseline was 6.65 (SD 0.95) in women, and 8.01 (SD 0.88) kg/m2 in men. At year 3, average change of ALMI was -0.09 (sd 0.34) kg/m2 (-1.35%) in women and - 0.17 (sd 0.33) kg/m2 (-2.0%) in men. None of the treatments individually or in combination had a benefit on ALMI change compared to control over 3 years, with omega-3s showing a small protective effect on ALMI at year 1 only (-0.021 vs. no-omega-3s -0.066 kg/m2, p = 0.001). Of 1940 non-sarcopenic participants at baseline, 88 (4.5%) developed incident sarcopenia over 3 years. None of the treatments individually or in combination reduced the odds of incident sarcopenia compared with placebo. CONCLUSION: Among healthy, physically active older adults, ALMI and incidence of sarcopenia were not improved by treatment of daily 2000 IU vitamin D, daily 1 g omega-3s, or a simple home exercise program compared with control over 3 years.
引用
- Eggimann AK, de Godoi Rezende Costa Molino C, Freystaetter G, et al. Effect of vitamin D, omega-3 supplementation, or a home exercise program on muscle mass and sarcopenia: DO-HEALTH trial. J Am Geriatr Soc. 2024. PMID: 39565152. doi:10.1111/jgs.19266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。